InvestorsHub Logo
Post# of 176828
Next 10
Followers 91
Posts 9926
Boards Moderated 0
Alias Born 08/09/2006

Re: eurama post# 60270

Friday, 07/29/2016 7:16:42 AM

Friday, July 29, 2016 7:16:42 AM

Post# of 176828
ADMD has the right to sub license Radiogel, they have exclusive worldwide rights to the product. Under that agreement batelle gets a percentage of sales as a royalty. Batelle would love for ADMD to outlicense the product and generate revenue for both ADMD and Batelle....Batelle is a research lab and doesn't have a licensing dept to shop this. ADMD had a personal relationship there thats how they got it and Batelle is relying on ADMD to monetize it. This is not a drug, this is a medical device so the patents are in perpetuity, they don't expire as some novices would suggest. They don't devalue over time. I can tell you there are already several companies sniffing around waiting for FDA approval to make their move
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News